Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Nil Dizdar"'
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Olfactory impairment is a central non-motor symptom in Parkinson's disease (PD). Previous studies have demonstrated that olfactory dysfunction is associated with mental illness and impaired cognition. The frequently investigated olfactory functions a
Externí odkaz:
https://doaj.org/article/2f9ea3b050bd40998a250f870c654350
Publikováno v:
Parkinson's Disease, Vol 2020 (2020)
Background. Parkinson’s disease is a neurodegenerative condition with both physical and mental consequences that affect many aspects of everyday life. Persons with Parkinson’s disease and their care partners want guidance from healthcare services
Externí odkaz:
https://doaj.org/article/1411e97cd3ab4b8cbb7a351913b143ea
Autor:
Camilla Fardell, Anna Zettergren, Caroline Ran, Andrea Carmine Belin, Agneta Ekman, Olof Sydow, Lars Bäckman, Björn Holmberg, Nil Dizdar, Peter Söderkvist, Hans Nissbrandt
Publikováno v:
BMC Medical Genetics, Vol 19, Iss 1, Pp 1-9 (2018)
Abstract Background In this study we investigated the association between SNPs in the S100B gene and Parkinson’s disease (PD) in two independent Swedish cohorts. The SNP rs9722 has previously been shown to be associated with higher S100B concentrat
Externí odkaz:
https://doaj.org/article/203f3fde04324870a6d00a61f5455499
Autor:
Charalampos Georgiopoulos, Suzanne T. Witt, Sven Haller, Nil Dizdar, Helene Zachrisson, Maria Engström, Elna-Marie Larsson
Publikováno v:
NeuroImage: Clinical, Vol 23, Iss , Pp - (2019)
Olfactory dysfunction is an early manifestation of Parkinson's disease (PD). The present study aimed to illustrate potential differences between PD patients and healthy controls in terms of neural activity and functional connectivity within the olfac
Externí odkaz:
https://doaj.org/article/2ddb507dcb334225ade5e25ced563090
Publikováno v:
BioTechniques, Vol 33, Iss 5, Pp 1000-1002 (2002)
Externí odkaz:
https://doaj.org/article/1f9425a4c1bd4215a888b01f2b82b53e
Autor:
Arja Höglund, Peter Hagell, Thomas Willows, Johan Rådberg, Anders Johansson, Berit Löwed, Anne-Christine Sjöström, Nil Dizdar, Margareth Lundgren, Eva-Lena Johansson, Filip Bergquist, Carina Karlberg, Carina Hellqvist
Publikováno v:
Journal of Neurology
Continuous subcutaneous (s.c.) apomorphine infusion is an effective therapy for Parkinson’s disease (PD), but a limitation is the formation of troublesome s.c. nodules. Various chemically non-identical apomorphine formulations are available. Anecdo
Publikováno v:
Parkinson's Disease
Parkinson's Disease, Vol 2020 (2020)
Parkinson's Disease, Vol 2020 (2020)
Background. Parkinson’s disease is a neurodegenerative condition with both physical and mental consequences that affect many aspects of everyday life. Persons with Parkinson’s disease and their care partners want guidance from healthcare services
Autor:
Filip Bergquist, Mats Ehrnebo, Dag Nyholm, Anders Johansson, Fredrik Lundin, Per Odin, Per Svenningsson, Fredrik Hansson, Leif Bring, Elias Eriksson, Nil Dizdar
Background and ObjectivesIntestinal levodopa/carbidopa gel infusion (LCIG) is superior to oral treatment in advanced Parkinson disease. The primary objective of this trial was to investigate whether continuous subcutaneous or intravenous infusion wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19e71ca890f43fd24020a2b629ab6c1e
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-188600
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-188600
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience
Olfactory impairment is a central non-motor symptom in Parkinson's disease (PD). Previous studies have demonstrated that olfactory dysfunction is associated with mental illness and impaired cognition. The frequently investigated olfactory functions a
Autor:
Filip, Bergquist, Anders, Johansson, Nil, Dizdar, Håkan, Widner, Dag, Nyholm, Per, Odin, Per, Svenningsson
Publikováno v:
Lakartidningen. 117
Parkinson's disease is the second most common neurodegenerative disease. Lewy bodies with alpha-synuclein as the major component and loss of dopaminergic nerve cells in substantia nigra are neuropathological features. The diagnosis of Parkinson's dis